John Kiely, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 34,116 shares at $8.38 ($286K) on 2024-11-22, disclosed to the SEC on 2024-11-26.
Open-market sale of $286k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.38 | 17,058 | $143K | 50.0% |
| 2 | $8.38 | 17,058 | $143K | 50.0% |
| Total | $8.38 avg | 34,116 | $286K | 100% |
| Filing → |
| AMRX | SELL | 2025-05-13 | $380K | — | Filing → |
| ZVO | BUY | 2020-09-10 | $43K | — | Filing → |
| AMRX | BUY | 2020-05-19 | $44K | — | Filing → |